Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Sirorat Kobbuaklee"'
Autor:
Chantana Polprasert, Chatphatai Moonla, Patcharee Komvilaisak, Thanawat Rattanathammethee, Sunisa Kongkiatkamon, Kitsada Wudhikarn, Sirorat Kobbuaklee, Pitchayut Boonyabaramee, Samart Pakakasama, Piya Rujkijyanont, Chane Choed-Amphai, Kamon Phuakpet, Saranya Pongudom, Udomsak Bunworasate, Darintr Sosothikul, Ponlapat Rojnuckarin
Publikováno v:
HemaSphere, Vol 7, p e18386d6 (2023)
Externí odkaz:
https://doaj.org/article/7b0070768955468caf0dff3eaf66a95d
Autor:
Chantana Polprasert, Pimjai Niparuck, Thanawat Rattanathammethee, Sirorat Kobbuaklee, Theerin Lanamtieng, Ponlapat Rojnuckarin
Publikováno v:
Hematology, Vol 27, Iss 1, Pp 1294-1297 (2022)
ABSTRACTIntroduction Risk stratification is essential for treatment decision in myelodysplastic neoplasms (MDS). Molecular international prognostic scoring system (M-IPSS) has been recently developed combining somatic mutations and clinical informati
Externí odkaz:
https://doaj.org/article/59d4a77f32e14aeb9930eb0abc44c570
Autor:
Chantana Polprasert, Sunisa Kongkiatkamon, Pimjai Niparuck, Thanawat Rattanathammethee, Kitsada Wudhikarn, Suporn Chuncharunee, Sirorat Kobbuaklee, Amornchai Suksusut, Theerin Lanamtieng, Panisinee Lawasut, Thiti Asawapanumas, Udomsak Bunworasate, Ponlapat Rojnuckarin
Publikováno v:
Hematology, Vol 27, Iss 1, Pp 765-771 (2022)
Introduction Myelodysplastic syndromes (MDS) predominantly present with varying degrees of cytopenia, while myelodysplastic syndromes/myeloproliferative neoplasms (MDS/MPN) exhibit proliferative features. Genetic defects underlying different complete
Externí odkaz:
https://doaj.org/article/d0d13dbfbf4647229388a86b42b55bc4
Autor:
Chatphatai Moonla, Chantana Polprasert, Patcharee Komvilaisak, Thanawat Rattanathammethee, Sunisa Kongkiatkamon, Kitsada Wudhikarn, Sirorat Kobbuaklee, Pitchayut Boonyabaramee, Nuanrat Tangcheewinsirikul, Samart Pakakasama, Piya Rujkijyanont, Chane Choed-Amphai, Kamon Phuakpet, Saranya Pongudom, Udomsak Bunworasate, Narittee Sukswai, Darintr Sosothikul, Ponlapat Rojnuckarin
Publikováno v:
Haematologica, Vol 108, Iss 10 (2023)
Germline HAVCR2 mutations are frequently detected in subcutaneous panniculitis-like T-cell lymphoma (SPTCL) patients with/without hemophagocytic lymphohistiocytosis (HLH) but factors associated with variable manifestations remain undetermined. To eva
Externí odkaz:
https://doaj.org/article/adb8ad283cfe4adb89af763e1976bfca
Autor:
Navavee Uman, Sirorat Kobbuaklee, Patsita Kansuwan, Phandee Watanaboonyongcharoen, Chantana Polprasert
Publikováno v:
Hematology Reports, Vol 14, Iss 1, Pp 13-18 (2022)
Background: Eosin-5-Maleimide (EMA)-based flow cytometry binds to red blood cell (RBC) membrane-associated proteins which can be used to detect red blood cell (RBC) membrane disorders. Myelodysplastic syndromes (MDS) are stem cell disorders resulting
Externí odkaz:
https://doaj.org/article/fc3fcb5674804beb880f21781e8f0bed
Publikováno v:
Leukemia & Lymphoma. 63:450-456
Dual targeting of TIM-3 and PD-1/PD-L1 pathways is currently under investigation for cancer immunotherapy. The interaction of these immune checkpoints remains unclear in the leukemic microenvironment of acute myeloid leukemia (AML). We performed an i
Autor:
Sunisa Kongkiatkamon, Chupong Ittiwut, Thanawat Rattanathammethee, Wanna Chetruengchai, Kitsada Wudhikarn, Sirorat Kobbuaklee, Amornchai Suksusut, Pimjai Niparuck, Noppacharn Uaprasert, Suporn Chuncharunee, Udomsak Bunworasate, Kanya Suphapeetiporn, Ponlapat Rojnuckarin, Chantana Polprasert
Publikováno v:
Blood. 140:8674-8675
Autor:
Pitchayut Boonyabaramee, Chantana Polprasert, Sunisa Kongkiatkamon, Sirorat Kobbuaklee, Rung Settapiboon, Saranya Pongudom, Saruta Faknuam, Ponlapat Rojnuckarin
Publikováno v:
Blood. 140:8316-8317
Autor:
Pimjai Niparuck, Ponlapat Rojnuckarin, Thanawat Rattanathammethee, Sunisa Kongkiatkamon, Theerin Lanamtieng, Sasinipa Trithiphen, Kritanan Songserm, Chantiya Chanswangphuwana, Udomsak Bunworasate, Amornchai Suksusut, Sirorat Kobbuaklee, Panisinee Lawasut, Suporn Chuncharunee, Chantana Polprasert
Publikováno v:
Clinical lymphoma, myelomaleukemia. 22(5)
BACKGROUND : Unexplained cytopenia (UC) and low-risk myelodysplastic syndrome (MDS) are distinguished mainly by morphologic dysplasia, which sometimes shows inter-observer discrepancy. We hypothesized that gene mutations are strong prognostic factors
Publikováno v:
Asian Pacific journal of cancer prevention : APJCP. 22(12)
Erythropoiesis stimulating agents (ESAs) represents the principal treatments for anemia in patients with lower-risk myelodysplastic syndromes (MDS). Pre-treatment erythropoietin (EPO) level and previous blood transfusion requirement are the two major